Adjuvant Systemic Chemotherapy with Gemcitabine for Stage IV Pancreatic Cancer: A Preliminary Report of Initial Experience

Publisher： Karger

E-ISSN： 1421-9794|51|6|305-310

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.6, 2005-11, pp. : 305-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second-Line Combination Chemotherapy with Docetaxel for Cisplatin-Pretreated Refractory Metastatic Esophageal Cancer: A Preliminary Report of Initial Experience

By  

Chemotherapy, Vol. 53, Iss. 6, 2007-10 ,pp. : 449-453

Karger

Access to resources Recommend Favorite

Clinical Practice of Adjuvant Chemotherapy in Patients with Early-Stage Epithelial Ovarian Cancer

By  

Chemotherapy, Vol. 61, Iss. 6, 2016-04 ,pp. : 287-294

Karger

Access to resources Recommend Favorite

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Advanced Pancreatic Cancer Who Have Progressed on Gemcitabine-Based Therapy

By  

Chemotherapy, Vol. 59, Iss. 4, 2014-01 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy

By Ormanns Steffen   Haas Michael   Remold Anna   Kruger Stephan   Holdenrieder Stefan   Kirchner Thomas   Heinemann Volker   Boeck Stefan  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-05 ,pp. : 1094-1094

MDPI

Access to resources Recommend Favorite

Adjuvant Effect of Clarithromycin on Chemotherapy for Murine Lung Cancer

By  

Chemotherapy, Vol. 46, Iss. 1, 1999-12 ,pp. : 49-61

Karger

Access to resources Recommend Favorite